JP2013515474A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515474A5 JP2013515474A5 JP2012545436A JP2012545436A JP2013515474A5 JP 2013515474 A5 JP2013515474 A5 JP 2013515474A5 JP 2012545436 A JP2012545436 A JP 2012545436A JP 2012545436 A JP2012545436 A JP 2012545436A JP 2013515474 A5 JP2013515474 A5 JP 2013515474A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- variant
- nucleic acid
- acid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922659.8A GB0922659D0 (en) | 2009-12-24 | 2009-12-24 | Factor H |
| GB0922659.8 | 2009-12-24 | ||
| PCT/GB2010/002334 WO2011077102A1 (en) | 2009-12-24 | 2010-12-23 | Recombinant factor h and variants and conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013515474A JP2013515474A (ja) | 2013-05-09 |
| JP2013515474A5 true JP2013515474A5 (enExample) | 2014-02-20 |
Family
ID=41716988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545436A Abandoned JP2013515474A (ja) | 2009-12-24 | 2010-12-23 | 組換え体ｈ因子ならびにそのバリアントおよびコンジュゲート |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US8889374B2 (enExample) |
| EP (1) | EP2516464B1 (enExample) |
| JP (1) | JP2013515474A (enExample) |
| GB (1) | GB0922659D0 (enExample) |
| WO (1) | WO2011077102A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0922659D0 (en) | 2009-12-24 | 2010-02-10 | Univ Edinburgh | Factor H |
| FR2981661B1 (fr) * | 2011-10-25 | 2015-06-19 | Lfb Biotechnologies | Procede de preparation du facteur h humain |
| FR3015484A1 (fr) * | 2013-12-20 | 2015-06-26 | Lab Francais Du Fractionnement | Proteines recombinantes possedant une activite de facteur h |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| RU2727411C2 (ru) | 2015-09-24 | 2020-07-21 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Композиция и способ для лечения заболевания, опосредованного комплементом |
| WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
| GB201706808D0 (en) | 2017-04-28 | 2017-06-14 | Univ Newcastle | Modified complement proteins and uses thereof |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| EP3824095A4 (en) * | 2018-07-20 | 2022-04-20 | University of Utah Research Foundation | GENE THERAPY FOR MACULATE GENERATION |
| ES2974200T3 (es) * | 2018-09-13 | 2024-06-26 | Regeneron Pharma | Rata nuligénica para el gen del factor H del complemento como modelo de glomerulopatía C3 |
| IL299048A (en) | 2020-06-14 | 2023-02-01 | Vertex Pharma | Variants of complement factor - 1 fusion structures and preparations containing them and their uses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7037504B2 (en) | 2001-10-23 | 2006-05-02 | Waratah Pharmaceuticals, Inc. | Epidermal growth factor protein and gene, and methods of use therefor |
| EP1336618A1 (en) | 2002-02-15 | 2003-08-20 | HANS-KNÖLL-INSTITUT FÜR NATURSTOFF-FORSCHUNG e.V. | Porcine complement regulator factor H and its use |
| EP2357257B1 (en) | 2005-02-14 | 2019-07-31 | University of Iowa Research Foundation | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| WO2007038995A1 (en) | 2005-09-19 | 2007-04-12 | Csl Behring Gmbh | Factor h for the treatment of chronic nephropathies and production thereof |
| AU2007261315B2 (en) * | 2006-06-21 | 2012-10-25 | Musc Foundation For Research Development | Targeting complement factor H for treatment of diseases |
| EP2208737B1 (en) | 2007-05-03 | 2017-07-05 | Lysomab GmbH | Complement factor H-derived short consensus repeat-antibody constructs |
| WO2008139496A1 (en) | 2007-05-16 | 2008-11-20 | Bigtec Private Limited | Recombinant human insulin and a method thereof |
| GB0922659D0 (en) | 2009-12-24 | 2010-02-10 | Univ Edinburgh | Factor H |
| EP2533797A1 (en) | 2010-02-12 | 2012-12-19 | CeMM Forschungszentrum für Molekulare Medizin GmbH | Complement factor h for oxidative stress disease conditions |
| WO2013142362A1 (en) | 2012-03-19 | 2013-09-26 | The Trustees Of The University Of Pennsylvania | Regulator of complement activation and uses thereof |
-
2009
- 2009-12-24 GB GBGB0922659.8A patent/GB0922659D0/en not_active Ceased
-
2010
- 2010-12-23 US US13/518,614 patent/US8889374B2/en active Active
- 2010-12-23 EP EP10803266.5A patent/EP2516464B1/en not_active Not-in-force
- 2010-12-23 JP JP2012545436A patent/JP2013515474A/ja not_active Abandoned
- 2010-12-23 WO PCT/GB2010/002334 patent/WO2011077102A1/en not_active Ceased
-
2014
- 2014-11-14 US US14/541,834 patent/US20150139975A1/en not_active Abandoned
-
2017
- 2017-04-10 US US15/483,814 patent/US10378005B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515474A5 (enExample) | ||
| NZ598351A (en) | Il-17 binding compounds and medical uses thereof | |
| JP2019530463A5 (enExample) | ||
| JP2012522529A5 (enExample) | ||
| JP7501356B2 (ja) | 融合タンパク質 | |
| JP2010534486A5 (enExample) | ||
| JP2009529856A5 (enExample) | ||
| JP2012525844A5 (enExample) | ||
| JP2012082206A5 (enExample) | ||
| JP2005533481A5 (enExample) | ||
| MX2012015142A (es) | Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo. | |
| NZ603623A (en) | Tcr complex immunotherapeutics | |
| He et al. | Identification of SCARA3, SCARA5 and MARCO of class A scavenger receptor-like family in Pseudosciaena crocea | |
| EA201101553A1 (ru) | Полипептид, деградирующий углеводы, и его применения | |
| JP2014514921A5 (enExample) | ||
| WO2012077950A3 (ko) | 히알루론산-단백질 컨쥬게이트 및 이의 제조 방법 | |
| HRP20192080T1 (hr) | Terapeutske fuzije nukleaza-albumine i postupci | |
| JP2013530689A5 (enExample) | ||
| MX2012005864A (es) | Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas. | |
| JP2018537089A5 (enExample) | ||
| JP2013523718A5 (enExample) | ||
| NZ593893A (en) | Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases | |
| JP2012529293A5 (enExample) | ||
| JP2009520758A5 (enExample) | ||
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs |